Financial results - CORAL-PHARM SRL

Financial Summary - Coral-Pharm Srl
Unique identification code: 17226690
Registration number: J06/120/2005
Nace: 4773
Sales - Ron
467.911
Net Profit - Ron
5.915
Employees
2
Open Account
Company Coral-Pharm Srl with Fiscal Code 17226690 recorded a turnover of 2024 of 467.911, with a net profit of 5.915 and having an average number of employees of 2. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Coral-Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 187.168 187.994 197.987 210.859 237.763 298.439 307.305 354.787 427.708 467.911
Total Income - EUR 187.172 187.997 197.990 211.928 244.039 303.458 307.312 354.797 427.716 467.937
Total Expenses - EUR 174.790 176.810 189.305 198.581 228.248 275.259 287.288 339.666 389.801 448.102
Gross Profit/Loss - EUR 12.382 11.187 8.686 13.347 15.791 28.199 20.024 15.131 37.915 19.836
Net Profit/Loss - EUR 10.077 9.161 6.602 11.208 13.370 25.562 17.911 12.217 34.471 5.915
Employees 1 1 0 1 1 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 10.0%, from 427.708 euro in the year 2023, to 467.911 euro in 2024. The Net Profit decreased by -28.364 euro, from 34.471 euro in 2023, to 5.915 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Coral-Pharm Srl

Rating financiar

Financial Rating -
CORAL-PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Coral-Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Coral-Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Coral-Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Coral-Pharm Srl - CUI 17226690

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 21.958 16.325 11.426 8.251 6.992 21.277 19.570 22.740 18.725 12.648
Current Assets 90.595 70.661 79.039 86.492 101.890 120.819 155.151 140.799 152.998 169.882
Inventories 37.564 37.844 40.475 36.975 39.196 45.607 44.313 66.882 68.458 65.032
Receivables 23.739 14.657 33.968 44.306 41.661 54.517 60.355 73.353 76.370 80.772
Cash 29.292 18.160 4.596 5.212 21.032 20.695 50.483 564 8.170 24.079
Shareholders Funds 52.501 27.724 25.101 31.550 39.673 60.033 71.296 43.178 54.270 15.654
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 60.052 59.262 65.364 63.193 69.208 82.063 103.425 120.361 117.453 166.876
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 169.882 euro in 2024 which includes Inventories of 65.032 euro, Receivables of 80.772 euro and cash availability of 24.079 euro.
The company's Equity was valued at 15.654 euro, while total Liabilities amounted to 166.876 euro. Equity decreased by -38.312 euro, from 54.270 euro in 2023, to 15.654 in 2024.

Risk Reports Prices

Reviews - Coral-Pharm Srl

Comments - Coral-Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.